Equoral, new cyclosporine drug delivery system, versus neoral: A bioequivalence study in healthy volunteers

被引：14

作者：

Andrysek, T ^{[1
]}

Masri, M

Jegorov, A

Veselsky, Z

Matha, V

机构：

[1] IVAX CR AS Opava, Opava 74770, Czech Republic

[2] Rizk Hosp, Beirut, Lebanon

[3] Univ Hosp, Hradec Kralove, Czech Republic

来源：

TRANSPLANTATION PROCEEDINGS | 2003年 / 35卷 / 01期

关键词：

D O I：

10.1016/S0041-1345(02)03924-6

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：207 / 209

页数：3

共 7 条

[1]

ANDRYSEK T, 1999, P S LIP SURF DISP SY, P187

[2] Comparison of cyclosporin a absorption from LCT and MCT solutions following intrajejunal administration in conscious dogs [J].

Behrens, D ;

Fricker, R ;

Bodoky, A ;

Drewe, J ;

Harder, F ;

Heberer, M .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (06) :666-668

[3]

HUGGER ED, 1999, B TECHN GATTEFOSSE, V92, P59

[4]

LEIGH M, 2001, DDS S, V1, P73

[5]

MOUNTFIELD RJ, 2000, P S MILL WORLD C PHA, P155

[6] The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system [J].

Nerurkar, MM ;

Burton, PS ;

Borchardt, RT .

PHARMACEUTICAL RESEARCH, 1996, 13 (04) :528-534

[7] INTESTINAL PERMEABILITY ENHANCEMENT - EFFICACY, ACUTE LOCAL TOXICITY, AND REVERSIBILITY [J].

SWENSON, ES ;

MILISEN, WB ;

CURATOLO, W .

PHARMACEUTICAL RESEARCH, 1994, 11 (08) :1132-1142

← 1 →